Officials with the Blue Ball Open presented the Parkview Foundation with a check in the amount of $6,200 in support of prostate cancer research. The donation will be appropriated to the Parkview Research Center to help fund ongoing and future prostate cancer research.
"From time to time, I relive the fear of the day I first learned I had prostate cancer. It's because of the awareness campaigns in place that I even thought to be tested," said Kent Hormann, Blue Ball Open Co-Chair. "Donating the proceeds from our most recent Blue Ball Golf Outing to Parkview is special for me. Parkview saved my life and it makes sense to donate these dollars to help raise awareness of and fight against prostate cancer."
The Blue Ball Open is a local golf outing focused on raising funds to support education and awareness of prostate cancer. 100% of the funds raised each year are given to outreach programs and services in the Fort Wayne area that support men who are dealing with a prostate cancer diagnosis.
"Awareness of the importance of PSA screenings is critical to catching and treating this potentially deadly cancer but the issue that matters most to men diagnosed with the disease is finding better ways to diagnose and treat," expressed Cynthia Cornwell, Blue Ball Open Co-Chair. "That is why we have chosen to donate and support Parkview's prostate cancer research. It is up to the researchers to find that life-saving intervention."
"Community support from philanthropic events like the Blue Ball Open is invaluable for not only the success of the Parkview Research Center, but also the success of the research being conducted for the benefit of our patients and the medical community," said Michael J. Mirro, MD, FACC, Medical Director of Parkview Research Center.
Parkview Research Center is currently conducting eight unique prostate cancer treatment studies in addition to a Prostate Cancer Survivorship research study. The Survivorship Program focuses on spiritual, psychological, physical and financial adjustments prostate cancer survivors face after treatment is complete. The program's vision is in alignment with the Parkview Research Center's Cancer Program Accredidation through the American College of Surgeons.